Hypothetical protein Cpn0308 is localized in the Chlamydm pneumoniae inclusion membrane

Infection and Immunity

Volumn 75, Issue 1, 2007, Pages 497-503

  Luo, Jianhua ^a   Jia, Tianjun ^a,b   Flores, Rhonda ^a   Chen, Ding ^a   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN;

ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; DISEASE COURSE; HYPOTHESIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CHLAMYDOPHILA PNEUMONIAE; HELA CELLS; HOST-PARASITE RELATIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR MEMBRANES; MICE; MICROSCOPY, CONFOCAL; PHOSPHOPROTEINS;

EID: 33846001351     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00935-06     Document Type: Article

References (31)

1. Bannantine, J. P., R. S. Griffiths, W. Viratyosin, W. J. Brown, and D. D. Rockey. 2000. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol. 2:35-47.
2. Campbell, L. A., and C. C. Kuo. 2002. Chlamydia pneumoniae pathogenesis. J. Med. Microbiol. 51:623-625.
3. Campbell, L. A., and C. C. Kuo. 2004. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2:23-32.
4. Campbell, L. A., T. Nosaka, M. E. Rosenfeld, K. Yaraei, and C. C. Kuo. 2005. Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice. Infect. Immun. 73:3164-3165.
5. Carabeo, R. A., D. J. Mead, and T. Hackstadt. 2003. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl. Acad. Sci. USA 100:6771-6776.
6. Fan, P., F. Dong, Y. Huang, and G. Zhong. 2002. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors is required for major histocompatibility complex antigen expression. Infect. Immun. 70:345-349.
7. Fling, S. P., R. A. Sutherland, L. N. Steele, B. Hess, S. E. D'Orazio, J. Maisonneuve, M. F. Lampe, P. Probst, and M.N. Starnbach. 2001. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 98:1160-1165.
8. Grayston, J. T. 1992. Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Med. 43:317-323.
9. Hackstadt, T. 1998. The diverse habitats of obligate intracellular parasites. Curr. Opin. Microbiol. 1:82-87.
10. Hackstadt, T., E. R. Fischer, M. A. Scidmore, D. D. Rockey, and R. A. Heinzen. 1997. Origins and functions of the chlamydial inclusion. Trends Microbiol. 5:288-293.
11. Hackstadt, T., D. D. Rockey, R. A. Heinzen, and M. A. Scidmore. 1996. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 15:964-977.
12. Hackstadt, T., M. A. Scidmore, and D. D. Rockey. 1995. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. USA 92: 4877-4881.
13. Hackstadt, T., M. A. Scidmore-Carlson, E. I. Shaw, and E. R. Fischer. 1999. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol. 1:119-130.
14. Hu, H., G. N. Pierce, and G. Zhong. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Investig. 103:747-753.
15. Kalman, S., W. Mitchell, R. Marathe, C. Lammel, J. Fan, R. W. Hyman, L. Olinger, J. Grimwood, R. W. Davis, and R. S. Stephens. 1999. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21:385-389.
16. Kuo, C. C., L. A. Campbell, and M. E. Rosenfeld. 2002. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations. Circulation 105:E34.
17. Kuo, C. C., J. T. Grayston, L. A. Campbell, Y. A. Goo, R. W. Wissler, and E. P. Benditt. 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA 92:6911-6914.
18. Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
19. Liu, L., H. Hu, H. Ji, A. D. Murdin, G. N. Pierce, and G. Zhong. 2000. Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol. Cell Biochem. 215:123-128.
20. Rockey, D. D., R. A. Heinzen, and T. Hackstadt. 1995. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol. Microbiol. 15:617-626.
21. Rockey, D. D., M. A. Scidmore, J. P. Bannantine, and W. J. Brown. 2002. Proteins in the chlamydial inclusion membrane. Microbes Infect. 4:333-340.
22. Scidmore, M. A., E. R. Fischer, and T. Hackstadt. 1996. Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J. Cell Biol. 134:363-374.
23. Sharma, J., Y. Niu, J. Ge, G. N. Pierce, and G. Zhong. 2004. Heat-inactivated C. pneumoniae organisms are not atherogenic. Mol. Cell Biochem. 260:147-152.
24. Sharma, J., Y. Zhong, F. Dong, J. M. Piper, G. Wang, and G. Zhong. 2006. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 74:1490-1499.
25. Shaw, A. C., B. B. Vandahl, M. R. Larsen, P. Roepstoft, K. Gevaert, J. Vandekerckhove, G. Christiansen, and S. Birkelund. 2002. Characterization of a secreted Chlamydia protease. Cell Microbiol. 4:411-424.
26. Su, H., G. McClarty, F. Dong, G. M. Hatch, Z. K. Pan, and G. Zhong. 2004. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279:9409-9416.
27. Subtil, A., C. Parsot, and A. Dautry-Varsat. 2001. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologbus type III machinery. Mol. Microbiol. 39:792-800.
28. Toh, H., K. Miura, M. Shirai, and M. Hattori. 2003. In silico inference of inclusion membrane protein family in obligate intracellular parasites chlamydiae. DNA Res. 10:9-17.
29. Vandahl, B. B., A. Stensballe, P. Roepstorff, G. Christiansen, and S. Birkelund. 2005. Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell Microbiol. 7:825-836.
30. Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942.
31. Zhong, G., C. Reis e Sousa, and R. N. Germain. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94:13856-13861.